Epsilogen Receives MHRA Approval for Phase Ib Trial of MOv18 IgE in Treating Platinum-Resistant Ovarian Cancer

Epsilogen, a global leader in the development of immunoglobulin E (IgE) antibodies to treat cancer, today announces that the Clinical Trial Application f...

July 09, 2024 | Tuesday | News
Roche Receives CE Mark for Accu-Chek® SmartGuide CGM Solution, Empowering Diabetes Management in Europe

Roche  announced  that it has received the CE Mark for its Accu-Chek® SmartGuide continuous glucose monitoring (CGM) solution. This signifi...

July 09, 2024 | Tuesday | News
Ecolab Launches First-Ever 100% Plastic-Free Disinfectant Wipe for Hospitals

Ecolab solutions help clean 15 million patient rooms and 3.5 billion surgical instruments. To help healthcare providers deliver a clean and safe enviro...

July 04, 2024 | Thursday | News
Dawn Health Partners with Merck to Develop Digital Solution for Growth Hormone Disorders

Dawn Health, the digital health company pioneering patient-first innovation, has announced they are working with leading global pharmaceutical company, M...

July 01, 2024 | Monday | News
Moderna’s mRESVIA Receives Positive CHMP Opinion for RSV Vaccine in Adults 60+

Moderna,  announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion ...

July 01, 2024 | Monday | News
WHO Awards Prequalification to Roche's HPV Test for Broad Use, Enhancing Global Cervical Cancer Screening

The World Health Organization (WHO) has awarded Roche's human papillomavirus (HPV) test prequalification designations for use on the cobas 5800 System ...

June 27, 2024 | Thursday | News
Metabolon Secures NIH Grant to Develop Innovative Monitoring Tool for Type 1 Diabetes Progression

Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic develop...

June 26, 2024 | Wednesday | News
ANEW Medical Explores Pioneering Therapeutics and Diagnostics with Secreted Klotho Proteins

ANEW to explore therapeutics and specialty diagnostics utilizing the s-KL protein and will pursue other medical product development and commercial oppo...

June 26, 2024 | Wednesday | News
Junshi Biosciences' Toripalimab Approved in China for First-Line Treatment of Extensive-Stage Small Cell Lung Cancer

Shanghai Junshi Biosciences , a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of nov...

June 18, 2024 | Tuesday | News
LIXTE Biotechnology Announces Clinical Trial Collaboration with Roche and NKI for MSI Low Metastatic Colon Cancer

LIXTE Biotechnology Holdings, Inc.  a clinical stage pharmaceutical company, today announced a collaboration with Roche and the Netherlands Cancer I...

June 17, 2024 | Monday | News
UCB Presents Promising Data on Certolizumab Pegol for Pregnant Women and High RF RA Patients at EULAR 2024

  Pharmacokinetic data from the CHERISH study suggest that pregnant women treated with certolizumab pegol can maintain their do...

June 17, 2024 | Monday | News
Biosplice Therapeutics and Novo Nordisk Partner to Develop Innovative Diabetes Treatments Targeting DYRK Inhibition

  Biosplice Therapeutics, Inc. (“Biosplice”), a clinical-stage biotechnology company pioneering first-in-class therapeutics based on smal...

June 13, 2024 | Thursday | News
Global Cancer Cases Set to Surge to 32 Million Annually by 2050, with Dramatic Increases in Low-Income Countries

Cancer incidence is expected to rise significantly through 2050, particularly in lower-income countries, to 32 million new cases annually – a pot...

June 11, 2024 | Tuesday | Reports
Adcytherix Launches with €30 Million Seed Funding to Pioneer Next-Generation Antibody-Drug Conjugates for Cancer Treatment

Vision is to establish a leading ADC developer to treat high unmet need diseases such as cancer. Founded by the team that founded and sold Emergence T...

June 11, 2024 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close